Form D · Other Health Care

NeuSpera Medical Inc.

San Jose, CA · CIK 0001674003

Offering snapshot reported Jun 24, 2021 · SEC filing

Reported sold
$65.7M
Offering amount: $79.6M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 9, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 24, 2021Initial$65,714,257No comparison17SEC filing
Jan 25, 2018Initial$14,000,001No comparison10SEC filing
Jun 13, 2016Amendment$8,888,888$888,889vs May 10, 20164SEC filing
May 10, 2016Initial$7,999,999No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-404066

Source: Form D, filed Jun 24, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Imran Eba Director
Adam Fine Director
Lori Hu Director
Mudit K. Jain Director
Milton M. Morris Director, Executive
Art Taylor Director
Alexander Yeh Executive
Ching Zhu Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
51 Daggett Drive
San Jose, CA, 95134